Zai Lab Announces the Inclusion of AUGTYRO® (repotrectinib) for ROS1+ NSCLC and Other Updates in China’s National Reimbursement Drug List
SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the 2024 National Reimbursement Drug List...

GIFT Nifty’s 23.5-hour trading made its cues faster, not calmer
Manish Goel Makes Bigg Boss 20 Headlines as Corporate Leadership Shifts Unfold
Liverpool chase fourth straight win at Fenerbahce on difficult Istanbul trip
Real Madrid Head to Greece Seeking Fourth Straight Champions League Win Against AEK Athens
Nabeela Syed flips the Illinois seat Republicans spent a record sum to keep 



























